CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma
Główni autorzy: | Guang Wang, Juan Fu, Mulin Liu, Qin Zheng |
---|---|
Format: | Artykuł |
Język: | English |
Wydane: |
Public Library of Science (PLoS)
2024-01-01
|
Seria: | PLoS ONE |
Dostęp online: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793908/?tool=EBI |
Podobne zapisy
-
CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma.
od: Guang Wang, i wsp.
Wydane: (2024-01-01) -
Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
od: Jiacheng Huang, i wsp.
Wydane: (2021-08-01) -
The role of CXC cytokines as biomarkers and potential targets in hepatocellular carcinoma
od: Yonghui Wang, i wsp.
Wydane: (2020-01-01) -
The Role of CXC Chemokines in Cardiovascular Diseases
od: Xiyi Lu, i wsp.
Wydane: (2022-05-01) -
Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico Approach
od: Tesfaye Wolde, i wsp.
Wydane: (2024-02-01)